Mark Lomaga

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

Mark Lomaga, Wen‐Chen Yeh, Ildiko Sarosi et al. · Genes & Development · 1999 · 1.3K citations · Full text

Life Sciences, Immunology, Pathobiology +12

Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study

Kristian Reich, Andreas Pinter, J.‐P. Lacour et al. · British Journal of Dermatology · 2017 · 188 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

Andrew Blauvelt, Kim Papp, Alice B. Gottlieb et al. · British Journal of Dermatology · 2019 · 172 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +15

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis

Mark Lebwohl, Leon Kircik, Angela Moore et al. · JAMA · 2022 · 113 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) Deficiency Results in Exencephaly and Is Required for Apoptosis within the Developing CNS

Mark Lomaga, Jeffrey T. Henderson, Andrew Elia et al. · Journal of Neuroscience · 2000 · 88 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17